Why Chewy Stock Is Plunging This Week

Chewy shares fell 11% during the week despite Q2 sales growth of 7.3% and adjusted EPS growth of 9.1%, as analysts flagged a one-time tariff benefit that made the earnings beat less compelling. Active customers rose 3.8% to 21.7 million, Autoship revenue increased 9.3%, and Chewy Vet Care clinic revenue grew by triple digits. Management raised fiscal 2026 revenue-growth guidance to 6.8%-7.7%, but cited a still-pressured consumer backdrop; Chewy says it is outperforming the broader pet category by roughly 2x-3x.

Analysis

The selloff creates a potential quality-of-earnings reset rather than a clear deterioration in CHWY’s underlying competitive position. The key question is whether the tariff-related benefit merely pulled margin forward or masks a more persistent gross-margin headwind from mix, promotions, and freight; the distinction matters because CHWY’s valuation support depends on sustained EBITDA conversion, not modest top-line outgrowth alone. Autoship’s scale should reduce revenue volatility, but its maturity also means incremental customer-spend gains—not subscriber growth—will increasingly determine operating leverage.

CVC is strategically more important than near-term consolidated revenue: successful clinic density can raise retention, shift higher-margin prescription and care spending into the ecosystem, and reduce customer-acquisition dependence. The counterpoint is that veterinary expansion is capital- and labor-intensive, so rapid clinic revenue growth could dilute free-cash-flow conversion before it improves it. This creates an execution contrast with PETS, whose asset-light model lacks the same retention optionality but also avoids clinic build-out risk.

Near term, the market is likely to focus on normalization of the one-off benefit and any evidence that discretionary pet categories remain weak. Over 1-3 months, a stable demand backdrop plus no further estimate cuts could permit a rerating from depressed expectations; over 6-18 months, the investable thesis requires CVC contribution margins and Autoship spend growth to offset slower core-category growth. Consensus may be underweighting the possibility that the apparent earnings-quality issue is transient, but also over-crediting the headline valuation if lease-adjusted clinic investment materially suppresses FCF.

Key Decisions for Investors

• Initiate a starter long CHWY only after post-earnings volatility stabilizes; target a 3-6 month holding period. Add if management confirms tariff-benefit reversal is contained and reiterates or raises EBITDA/FCF expectations next quarter; risk is a second guide-down tied to gross margin or consumer demand.
• Structure the exposure as long CHWY / short PETS in equal dollar amounts for 6-12 months. The pair isolates Chewy’s ecosystem and veterinary-retention upside against a more mature, lower-growth online pet retailer; exit if CHWY’s active-customer growth decelerates below category growth or CVC losses expand faster than expected.
• Do not chase short-dated CHWY calls: implied volatility is likely elevated after the earnings reaction and the next fundamental proof point is quarterly, not days away. For upside participation, consider 6-9 month call spreads only after assessing next-quarter consensus EBITDA, using the prior earnings-gap low as the technical invalidation level.
• Monitor three alerts before increasing exposure: sequential gross-margin movement excluding tariff effects, Autoship net-spend growth versus active-customer growth, and CVC clinic-level contribution/lease commitments. A material reduction in full-year EBITDA or FCF guidance would falsify the valuation-recovery thesis regardless of revenue growth.